secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0001372514-23-000129
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharma appoints Praveen Tyle as Chairman; Paul Chaney retires after 17 years
--------------------------------------------------------------------------------

- Paul Chaney resigned as Chairman and Board member effective Sept 20, 2023; no disagreement cited.
- Praveen Tyle, PhD, appointed Chairman effective same date; also serves as director.
- Erin Parsons appointed Chair of Compensation Committee; Carmine Stengone joins Audit and Nominating Committees.
- Tyle to help guide development of KIO-301 for retinitis pigmentosa and other inherited retinal diseases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000129/0001372514-23-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000129/kprx-20230920.htm
  HTML page:      https://secwatch.observer/filing/0001372514-23-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer